Table 1.
Subject’s age, bodyweight, injected dose of 18F-FDG, and uptake time: means ± standard deviation
| All patients | NHL | HL | Sarcoma | |
|---|---|---|---|---|
| Age, years |
10.33 ± 4.97 [1–17] |
9.8 ± 5.0 | 13.1 ± 3.7 | 8.7 ± 5.2 |
| Bodyweight, kg |
38.50 ± 20.69 [7.0–89.5] |
36.3 ± 20.3 | 49.9 ± 15.4 | 32.2 ± 21.9 |
| 18F-FDG dose, MBq |
134.97 ± 53.65 [41–246] |
129.8 ± 51.8 | 155.1 ± 40.9 | 124.3 ± 62.0 |
| Uptake time, min |
70.14 ± 16.94 [46–126] |
69.0 ± 12.7 | 59.9 ± 7.4 | 78.7 ± 21.7 |
NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma. Uptake time: time between PET tracer injection and the beginning of imaging in minutes